» Articles » PMID: 12414958

Suppression of Tetradecanoyl Phorbol Acetate-induced Lytic Reactivation of Kaposi's Sarcoma-associated Herpesvirus by K1 Signal Transduction

Overview
Journal J Virol
Date 2002 Nov 5
PMID 12414958
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The K1 protein of Kaposi's sarcoma-associated herpesvirus (KSHV) contains an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic region and elicits cellular signal transduction through this motif. To investigate the role of K1 signal transduction in KSHV replication, we expressed full-length K1 and CD8-K1 chimeras in BCBL1 cells. Unlike its strong signaling activity in uninfected B lymphocytes, K1 did not induce intracellular calcium mobilization or NF-AT activation at detectable levels in KSHV-infected BCBL1 cells. Instead, K1 signaling dramatically suppressed KSHV lytic reactivation induced by tetradecanoyl phorbol acetate (TPA) stimulation, but not by ORF50 ectopic expression. Mutational analysis showed that the cytoplasmic ITAM sequence of K1 was required for this suppression. Viral microarray and immunoblot analyses demonstrated that K1 signaling suppressed the TPA-mediated increase in the expression of a large subset of viral lytic genes in KSHV-infected BCBL1 cells. Furthermore, electrophoretic mobility shift assays demonstrated that TPA-induced activation of AP-1, NF-kappaB, and Oct-1 activities was severely diminished in BCBL1 cells expressing the K1 cytoplasmic domain. The reduced activities of these transcription factors may confer the observed reduction in viral lytic gene expression. These results demonstrate that K1-mediated signal transduction in KSHV-infected cells is profoundly different from that in KSHV-negative cells. Furthermore, K1 signal transduction efficiently suppresses TPA-mediated viral reactivation in an ITAM-dependent manner, and this suppression may contribute to the establishment and/or maintenance of KSHV latency in vivo.

Citing Articles

Unraveling the Kaposi Sarcoma-Associated Herpesvirus (KSHV) Lifecycle: An Overview of Latency, Lytic Replication, and KSHV-Associated Diseases.

Losay V, Damania B Viruses. 2025; 17(2).

PMID: 40006930 PMC: 11860327. DOI: 10.3390/v17020177.


The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target.

Abere B, Mamo T, Hartmann S, Samarina N, Hage E, Ruckert J PLoS Pathog. 2017; 13(9):e1006639.

PMID: 28938025 PMC: 5627962. DOI: 10.1371/journal.ppat.1006639.


Kaposi sarcoma herpesvirus pathogenesis.

Mariggio G, Koch S, Schulz T Philos Trans R Soc Lond B Biol Sci. 2017; 372(1732).

PMID: 28893942 PMC: 5597742. DOI: 10.1098/rstb.2016.0275.


The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Augments Viral Lytic Replication.

Zhang Z, Chen W, Sanders M, Brulois K, Dittmer D, Damania B J Virol. 2016; 90(17):7657-66.

PMID: 27307571 PMC: 4988170. DOI: 10.1128/JVI.03102-15.


MiRNA-891a-5p mediates HIV-1 Tat and KSHV Orf-K1 synergistic induction of angiogenesis by activating NF-κB signaling.

Yao S, Hu M, Hao T, Li W, Xue X, Xue M Nucleic Acids Res. 2015; 43(19):9362-78.

PMID: 26446987 PMC: 4627096. DOI: 10.1093/nar/gkv988.


References
1.
Gao S, Zhang Y, Deng J, Rabkin C, Flore O, Jenson H . Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes. J Infect Dis. 1999; 180(5):1466-76. DOI: 10.1086/315098. View

2.
Samaniego F, Pati S, Karp J, Prakash O, Bose D . Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation?. J Natl Cancer Inst Monogr. 2001; (28):15-23. DOI: 10.1093/oxfordjournals.jncimonographs.a024252. View

3.
Cotter 2nd M, Robertson E . The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology. 1999; 264(2):254-64. DOI: 10.1006/viro.1999.9999. View

4.
Longnecker R, Druker B, Roberts T, Kieff E . An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J Virol. 1991; 65(7):3681-92. PMC: 241385. DOI: 10.1128/JVI.65.7.3681-3692.1991. View

5.
Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M . Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature. 2000; 406(6795):536-40. DOI: 10.1038/35020115. View